Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantationMeng Zhang, Mingfeng Zhao, Juanxia Meng et al.|Frontiers in Immunology|2025Cited by 12
Anti-FcRL5 CAR-T exhibits anti-MM activity against EMM after progression of anti-BCMA and anti-GPRC5D CAR-T: a case reportXiaoyuan He, Mingfeng Zhao, Xiaomei Zhang et al.|Blood Advances|2024Cited by 5
Early intrathecal dexamethasone and methotrexate as an effective approach for immune effector cell-associated neurotoxicity syndrome after CAR-T cell therapiesJuanxia Meng, Mingfeng Zhao, Hairong Lyu et al.|Frontiers in Immunology|2025Cited by 2
Regulation and Mechanistic Investigation of CAR-T Cell Exhaustion by ADRB-Mediated β-Adrenergic SignalingJianming Xu, Mingfeng Zhao, Jile Liu et al.|SSRN Electronic Journal|2025Cited by 0